Literature DB >> 11177386

Epidemiology of HIV in Estonia.

V Ustina1, K Zilmer, L Tammai, M Raukas, A Andersson, E Lilja, J Albert.   

Abstract

The aim of this study was to report on the epidemiology of HIV infection in Estonia and to molecularly characterize Estonian HIV-1 variants. Epidemiological data were obtained from the Estonian National HIV/AIDS Database. In 1995-1996 blood samples were collected from 54 of the 65 HIV-infected individuals that had been diagnosed at that time. The V3 domain of the env gene was directly sequenced from peripheral blood mononuclear cells of 49 of these 54 individuals and the sequences used for phylogenetic analyses. At the end of 1999 Estonia reported 96 diagnosed HIV cases; 46 (48%) were homosexual or bisexual men and 31 (32%) were presumed to have been infected heterosexually. Importantly, only four individuals were likely to have become infected through intravenous drug use. Forty-three individuals (45%) were presumed to have been infected outside of Estonia, whereas 38 (40%) were likely to have become infected in Estonia. As expected, a majority of the investigated individuals (80%) were found to carry subtype B virus. Infections with subtypes A, C, D, G, and CRF02_AG were also documented. The dominance of subtype B was restricted to homosexual and bisexual men. Thus, subtype B infections were documented in 33 of 34 (97%) homosexual and bisexual men, but only 6 of 15 (40%) individuals with other probable routes of infection. Thirty of the 39 subtype B sequences were joined in a tight sequence cluster that also included sequences from neighboring Russia and Lithuania. This pattern suggests a local spread of HIV-1 among homosexual and bisexual men within the region. The results from the phylogenetic analyses agreed well with other epidemiological information. In conclusion, Estonia remains a country with a low prevalence of HIV infection. A majority of the identified cases are homosexual or bisexual men, whereas HIV infection among intravenous drug users is rare. A large proportion of the homosexual and bisexual men carried closely related subtype B variants. The sequences have been deposited in GenBank under accession numbers AF286538-AF286586.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11177386     DOI: 10.1089/088922201750056816

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Compulsory screening of immigrants for tuberculosis and HIV.

Authors:  Richard Coker
Journal:  BMJ       Date:  2004-02-07

2.  Estonia at the threshold of the fourth decade of the AIDS era in Europe.

Authors:  Kaja-Triin Laisaar; Radko Avi; Jack DeHovitz; Anneli Uusküla
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-11       Impact factor: 2.205

3.  Multiple HIV-1 introductions into the Swedish intravenous drug user population.

Authors:  Helena Skar; Staffan Sylvan; Hans-Bertil Hansson; Olle Gustavsson; Hans Boman; Jan Albert; Thomas Leitner
Journal:  Infect Genet Evol       Date:  2008-04-08       Impact factor: 3.342

4.  Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.

Authors:  Harr F Njai; Gert Van der Auwera; Chiambah A Ngong; Leo Heyndrickx; Souleymane Sawadago; Hilton Whittle; Phillipe Nyambi; Robert Colebunders; Guido van der Groen; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  Detailed molecular epidemiologic characterization of HIV-1 infection in Bulgaria reveals broad diversity and evolving phylodynamics.

Authors:  Ivailo Alexiev Ivanov; Danail Beshkov; Anupama Shankar; Debra L Hanson; Dimitrios Paraskevis; Viara Georgieva; Lyudmila Karamacheva; Hristo Taskov; Tonka Varleva; Ivaylo Elenkov; Mariana Stoicheva; Daniela Nikolova; William M Switzer
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

6.  The global spread of HIV-1 subtype B epidemic.

Authors:  Gkikas Magiorkinis; Konstantinos Angelis; Ioannis Mamais; Aris Katzourakis; Angelos Hatzakis; Jan Albert; Glenn Lawyer; Osamah Hamouda; Daniel Struck; Jurgen Vercauteren; Annemarie Wensing; Ivailo Alexiev; Birgitta Åsjö; Claudia Balotta; Perpétua Gomes; Ricardo J Camacho; Suzie Coughlan; Algirdas Griskevicius; Zehava Grossman; Anders Horban; Leondios G Kostrikis; Snjezana J Lepej; Kirsi Liitsola; Marek Linka; Claus Nielsen; Dan Otelea; Roger Paredes; Mario Poljak; Elizabeth Puchhammer-Stöckl; Jean Claude Schmit; Anders Sönnerborg; Danica Staneková; Maja Stanojevic; Dora C Stylianou; Charles A B Boucher; Georgios Nikolopoulos; Tetyana Vasylyeva; Samuel R Friedman; David van de Vijver; Gioacchino Angarano; Marie-Laure Chaix; Andrea de Luca; Klaus Korn; Clive Loveday; Vincent Soriano; Sabine Yerly; Mauricio Zazzi; Anne-Mieke Vandamme; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-02       Impact factor: 3.342

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.